Bibliographic information
Recommendation
In hospitalized patients with severe or critical COVID-19 and acute hypoxaemic respiratory failure (AHRF) not needing emergent intubation, we suggest continuous positive airway pressure (CPAP), rather than standard oxygen therapy
Recommended in favor
Conditional
Notes and Remarks
The GDG chose not to make a recommendation regarding optimal interface for CPAP, whether helmet or face mask, given the lack of direct data available for the comparison. The choice between interface should be guided by clinician experience, availability, and patient comfort. The GDG chose not to make a recommendation regarding HFNO versus CPAP due to the uncertainty of the data. Clinicians should choose between the three on the basis of considerations such as availability of devices and the local supply of oxygen, their personal comfort and experience with the relevant devices, and patient-specific considerations (such as claustrophobia that some patients experience with CPAP/NIV masks, and nasal discomfort that some patients experience with HFNO). Given the likely similar direction of benefit, the GDG chose to extend this recommendation to the paediatric age range (despite the absence of data), while emphasizing the need for more research in this population.
Practical info There is no specific recommendation as to the initial pressure to be used for CPAP, leaving to local clinical decision-making and patient-specific factors. Based on clinical experience of the GDG, there is a suggestion to start with a pressure of 5–10 cm H2O, titrated to patient comfort and work of breathing, with FiO2 titrated to achieve the target oxygen saturation when using facemask or oral-nasal mask. For use of helmet interfaces, additional information can be found in recent publications (355). For infection prevention precautions related to the use of these respiratory support devices, please refer to Chapter 5 on IPC. See also Research needs.
Also Featured In
This recommendation also appears in the following guidelines:
Clinical management of COVID-19: living guideline, 23 June 2022.
Clinical management of COVID-19: living guideline, 15 September 2022.
Clinical management of COVID-19: living guideline, 13 January 2023.
Clinical management of COVID-19: living guideline, 18 August 2023